Klotho Neurosciences, Inc. (KLTO) Earnings History
Net Loss4 years of earnings data (2021–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Klotho Neurosciences, Inc. (KLTO) Earnings Overview
As of June 13, 2026, Klotho Neurosciences, Inc. (KLTO) reported trailing twelve-month net income of -$11M. The company earned $-0.19 per diluted share over the past four quarters.
Looking at the long-term picture, KLTO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$598,593 in fiscal 2022.
Klotho Neurosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SAVA (-$106M net income), NRXP (-$25M net income, -2336.5% margin), ACIU (-$70M net income, -1971.6% margin), KLTO has comparable earnings metrics. Compare KLTO vs SAVA →
KLTO Earnings vs Peers
Earnings metrics vs comparable public companies
KLTO Historical Earnings Data (2021–2024)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$6M | -769.4% | -$6M | $-0.32 | - | - |
| 2023 | $-707,458 | -18.2% | $-631,322 | $-0.00 | - | - |
| 2022 | $-598,593 | +46.0% | $-574,374 | $-0.00 | - | - |
| 2021 | -$1M | - | -$1M | $-0.00 | - | - |
Download Data
Export KLTO earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in KLTO back in 2021?
Total return with dividends reinvested · 5+ years of data
Calculate ReturnsHow much would $100/month in KLTO be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs KLTO Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationKLTO vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowKLTO — Frequently Asked Questions
Quick answers to the most common questions about buying KLTO stock.
What is KLTO earnings per share (EPS)?
KLTO trailing twelve-month (TTM) diluted EPS is $-0.19, reflecting N/A year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2024 is available in the table on this page.
What is Klotho Neurosciences, Inc.'s net income?
Klotho Neurosciences, Inc. (KLTO) trailing twelve-month net income is $-11M as of 2024. Earnings declined N/A year-over-year.
Is KLTO profitable?
KLTO is not currently profitable on a TTM basis, reporting a net loss of $-11M. Net margin is N/A. Investors should monitor for a return to profitability.
What is KLTO's earnings growth rate?
KLTO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2024.
What are KLTO's profit margins?
Klotho Neurosciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -700.1%.
Is KLTO growing earnings?
KLTO TTM EPS: $-0.19. Net income: $-11M. YoY earnings change: N/A.
What was KLTO's best earnings year?
Klotho Neurosciences, Inc.'s highest annual net income on record is $-598593.00, achieved in fiscal year 2022. Earnings history on this page spans 2021 to 2024 and includes all annual and quarterly figures.
What were KLTO's earnings last quarter?
KLTO's most recent reported quarter was Q3 2025. Net income was $-3M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.